Anígilájé Emmanuel Adémólá, Bitto Terkaa Terrumun
Department of Paediatrics, Benue State University, P.M.B. 102119, Makurdi, Nigeria.
Department of Epidemiology and Community Health, Benue State University, P.M.B. 102119, Makurdi, Nigeria.
Int J Nephrol. 2013;2013:937268. doi: 10.1155/2013/937268. Epub 2013 Nov 25.
Background. Children with cerebral palsy (CP) are prone to urinary tract infection (UTI). Methods/Objectives. The prevalence and the predictors of UTI among children with CP were compared to age- and sex-matched children without CP at Federal Medical Centre, Makurdi, Nigeria, from December 2011 to May 2013. Results. The age range was between 2 and 15 years with a mean age of 8.63 ± 3.83 years including 30 males and 22 females. UTI was confirmed in 20 (38.5%) CP children compared to 2 children (3.8%) without CP (P value 0.000). Among CP children, Escherichia coli was the commonest organism isolated in 9 (9/20, 45.0%), Streptococcus faecalis in 4 (20.0%), and Staphylococcus aureus in 3 (15%), while both Proteus spp. and Klebsiella spp. were isolated in 2 children (10.0%) each. Escherichia coli was also found in the 2 children without CP. All the organisms were resistant to cotrimoxazole, nalidixic acid, nitrofurantoin, and amoxiclav, while they were 100% sensitive to ceftriaxone and the quinolones. In a univariate regression analysis, only moderate to severe gross motor dysfunction predicted the risk of UTI (OR = 54.81, 95% CI, 2.27-1324.00, P value 0.014). Conclusion. Efforts should be put in place to aid mobility among CP children in order to reduce the risk of UTI.
背景。脑瘫(CP)患儿易患尿路感染(UTI)。方法/目的。2011年12月至2013年5月,在尼日利亚马库尔迪联邦医疗中心,对脑瘫患儿与年龄和性别匹配的非脑瘫患儿的UTI患病率及预测因素进行了比较。结果。年龄范围在2至15岁之间,平均年龄为8.63±3.83岁,包括30名男性和22名女性。确诊UTI的脑瘫患儿有20例(38.5%),而非脑瘫患儿有2例(3.8%)(P值0.000)。在脑瘫患儿中,分离出的最常见病原体为大肠杆菌,共9例(9/20,45.0%),粪肠球菌4例(20.0%),金黄色葡萄球菌3例(15%),变形杆菌属和克雷伯菌属各有2例患儿分离出(10.0%)。在2例非脑瘫患儿中也发现了大肠杆菌。所有病原体对复方新诺明、萘啶酸、呋喃妥因和阿莫西林克拉维酸均耐药,而对头孢曲松和喹诺酮类药物100%敏感。在单因素回归分析中,只有中度至重度的粗大运动功能障碍可预测UTI风险(OR = 54.81,95%CI,2.27 - 1324.00,P值0.014)。结论。应采取措施帮助脑瘫患儿提高活动能力,以降低UTI风险。